Biocon's contract research arm Syngene International today posted 54.02 per cent rise in its net profit at Rs 74.7 crore for the second quarter ended September 30, driven by discovery and R&D centre business verticals.
The company, which had posted a net profit of Rs 48.5 crore during the same period of the previous fiscal, also announced acquisition of bio-informatics services of Strand Life Sciences along with a team of data scientists.
Net sales of the company rose to Rs 294.7 crore for the second quarter, as compared to Rs 256.1 crore during the same period of previous fiscal, Syngene International said in a regulatory filing.
The company, which had posted a net profit of Rs 48.5 crore during the same period of the previous fiscal, also announced acquisition of bio-informatics services of Strand Life Sciences along with a team of data scientists.
